AINDEX
Markets

BioStem Technologies, Inc. (BSEM)

BSEMNASDAQ-CMBiotechnology: Biological Products (No Diagnostic Substances)

$0.9350

-0.0349 (-3.60%) today

Pre-market, Nov 17, 4:00 PM ET

-21.43% 1D
Market cap
$17.93m
P/E
–
EPS, last 4 quarters
$-1.58
Dividend yield
–
Day range
–
52-week range
$0.9000 to $5.44
Average volume
–
Previous close
$0.9699

Analysts

1 covering

Buy1 buy, 0 hold, 0 sell

Targets a year out average $7.00, +648.7% from here

$7.00now $0.9350$7.00

Earnings

next estimate $-0.4500

Next report

Dec 2025

-150.0%

Mar 2026

-85.7%

Jun 2026

-4.0%

Sep 2026

-23.3%

estimate reported, and the surprise

News

8 latest

The company

BioStem Technologies, Inc. is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain, CryoTek and SteriTek processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.